Developing novel immunoassays specific for thyroid stimulating and tshblocking autoantibodies
Ended Project Grant Awarded Last action
- Award ID
- R44DK115298
- Recipient
-
Mediomics LLC UEI TT17CQEWLNF1
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,985,003
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Funding
-
- $1,489,906.00 Federal
- $495,097.00 Non-federal
- Place of performance
- Missouri, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $495,097 | $0 | |
| Amendment | $495,097 | $495,097 | |
| Original award | $499,712 | $0 |
Quick answers
Who received award R44DK115298?
R44DK115298 was awarded to Mediomics LLC by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 15, 2017.
How much is award R44DK115298 worth?
$1,985,003 has been obligated on R44DK115298: $1,489,906 in federal funding and $495,097 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award